Advertisement

Advertisement

HK:3692 Stock Latest News

Hansoh Pharma Wins NMPA Nod to Review New Injection for Kidney-Disease Complication

Company AnnouncementsHansoh Pharma Wins NMPA Nod to Review New Injection for Kidney-Disease Complication

Hansoh Pharmaceutical Reshapes Governance Team With New Joint Company Secretary

PremiumCompany Announcements

Hansoh Pharmaceutical Reshapes Governance Team With New Joint Company Secretary

1d ago

Hansoh Pharma Sets 2026 AGM to Approve 2025 Results, Dividend and Share Mandates

PremiumCompany Announcements

Hansoh Pharma Sets 2026 AGM to Approve 2025 Results, Dividend and Share Mandates

7d ago

Hansoh Pharma’s Weight-Loss Drug Olatorepatide Wins NDA Acceptance in China

PremiumCompany Announcements

Hansoh Pharma’s Weight-Loss Drug Olatorepatide Wins NDA Acceptance in China

8d ago

Hansoh Pharma Wins NMPA Breakthrough Status for Fourth-Gen Lung Cancer Drug

PremiumCompany Announcements

Hansoh Pharma Wins NMPA Breakthrough Status for Fourth-Gen Lung Cancer Drug

21d ago

Hansoh Pharmaceutical Reshuffles Company Secretary and Compliance Roles

PremiumCompany AnnouncementsHansoh Pharmaceutical Reshuffles Company Secretary and Compliance Roles

27d ago

Hansoh Pharma Wins NMPA Nod for Trial of New KRAS-Targeting Cancer Drug

Company Announcements

Hansoh Pharma Wins NMPA Nod for Trial of New KRAS-Targeting Cancer Drug

29d ago

Hansoh Pharmaceutical Wins Breakthrough Therapy Status for Esophageal Cancer ADC

Company Announcements

Hansoh Pharmaceutical Wins Breakthrough Therapy Status for Esophageal Cancer ADC

1M ago

Hansoh Pharmaceutical Expands RSU Share Pool With Market Purchases

PremiumCompany Announcements

Hansoh Pharmaceutical Expands RSU Share Pool With Market Purchases

1M ago

Hansoh Hands KiOmed Osteoarthritis Licence to Hengrui in Strategic Refocus

PremiumCompany Announcements

Hansoh Hands KiOmed Osteoarthritis Licence to Hengrui in Strategic Refocus

1M ago

Hansoh Pharma Wins China Nod for Trials of New Hypertension Drug HS-10522

PremiumCompany Announcements

Hansoh Pharma Wins China Nod for Trials of New Hypertension Drug HS-10522

1M ago

Hansoh Pharma Wins Breakthrough Therapy Designation in China for Prostate Cancer ADC

PremiumCompany Announcements

Hansoh Pharma Wins Breakthrough Therapy Designation in China for Prostate Cancer ADC

1M ago

Hansoh Pharmaceutical Sets Final 2025 Dividend at HKD 0.20 Per Share

PremiumCompany AnnouncementsHansoh Pharmaceutical Sets Final 2025 Dividend at HKD 0.20 Per Share

1M ago

Hansoh Pharma Grants 5 Million RSUs to Staff Under Post-IPO Incentive Scheme

Company Announcements

Hansoh Pharma Grants 5 Million RSUs to Staff Under Post-IPO Incentive Scheme

1M ago

Hansoh Pharma Overhauls Equity Incentives With New 2026 Share Scheme

Company Announcements

Hansoh Pharma Overhauls Equity Incentives With New 2026 Share Scheme

1M ago

Hansoh Pharma Wins China Breakthrough Therapy Status for Lung Cancer ADC Combo

PremiumCompany Announcements

Hansoh Pharma Wins China Breakthrough Therapy Status for Lung Cancer ADC Combo

2M ago

Hansoh Pharma Delivers Double-Digit 2025 Growth as Innovative Drugs Drive Earnings and Pipeline Wins

PremiumCompany Announcements

Hansoh Pharma Delivers Double-Digit 2025 Growth as Innovative Drugs Drive Earnings and Pipeline Wins

2M ago

Hansoh Pharmaceutical Proposes HKD 0.20 Final Dividend for 2025

PremiumCompany Announcements

Hansoh Pharmaceutical Proposes HKD 0.20 Final Dividend for 2025

2M ago

Hansoh Wins Third China Indication for XINYUE, Expanding Autoimmune Portfolio

PremiumCompany Announcements

Hansoh Wins Third China Indication for XINYUE, Expanding Autoimmune Portfolio

3M ago

Hansoh Pharma Wins NMPA Nod to Begin Trials of New Cancer Drug HS-10587

PremiumCompany AnnouncementsHansoh Pharma Wins NMPA Nod to Begin Trials of New Cancer Drug HS-10587

3M ago

Hansoh Pharma Wins NMPA Nod to Begin Trials for New PNH Drug

Company Announcements

Hansoh Pharma Wins NMPA Nod to Begin Trials for New PNH Drug

3M ago

Hansoh Pharma Sets March 29 Board Meeting to Approve 2025 Results and Consider Final Dividend

Company Announcements

Hansoh Pharma Sets March 29 Board Meeting to Approve 2025 Results and Consider Final Dividend

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >